Brief Consent Methods Enable Rapid Enrollment in Acute Stroke Trial: Results From the TICH-2 Randomized Controlled Trial

Author:

Law Zhe Kang12ORCID,Appleton Jason P.13,Scutt Polly1,Roberts Ian4,Al-Shahi Salman Rustam5,England Timothy J.6ORCID,Werring David J.7,Robinson Thompson8,Krishnan Kailash9ORCID,Dineen Robert A.1011ORCID,Laska Ann Charlotte12,Lyrer Philippe A.13,Egea-Guerrero Juan Jose14ORCID,Karlinski Michal15,Christensen Hanne16,Roffe Christine17ORCID,Bereczki Daniel18ORCID,Ozturk Serefnur19ORCID,Thanabalan Jegan20ORCID,Collins Ronan21,Beridze Maia22,Ciccone Alfonso23,Duley Lelia24ORCID,Shone Angela25ORCID,Bath Philip M.19,Sprigg Nikola19,

Affiliation:

1. Stroke Trials Unit, University of Nottingham, United Kingdom. (Z.K.L., J.P.A., P.S., P.M.B., N.S.)

2. Department of Medicine, National University of Malaysia. (Z.K.L.)

3. Stroke, University Hospitals Birmingham NHS Foundation Trust, United Kingdom (J.P.A.).

4. Clinical Trials Unit, London School of Hygiene and Tropical Medicine, United Kingdom (I.R.).

5. Centre for Clinical Brain Sciences, University of Edinburgh, United Kingdom (R.A.-S.S.).

6. Vascular Medicine, Division of Medical Sciences and GEM, Royal Derby Hospital Centre, University of Nottingham, United Kingdom. (T.J.E.)

7. Stroke Research Centre, UCL Queen Square Institute of Neurology, London, United Kingdom (D.J.W.).

8. Department of Cardiovascular Sciences and NIHR Biomedical Research Centre, University of Leicester, United Kingdom (T.R.).

9. Stroke, Nottingham University Hospitals NHS Trust, United Kingdom (K.K., P.M.B., N.S.).

10. Radiological Sciences, University of Nottingham, United Kingdom. (R.A.D.)

11. NIHR Nottingham Biomedical Research Centre, United Kingdom (R.A.D.).

12. Department of Clinical Sciences, Karolinska Institute Danderyd Hospital, Sweden (A.C.L.).

13. Department of Neurology and Stroke Center, University Hospital Basel and University of Basel, Switzerland (P.A.L.).

14. NeuroCritical Care Unit, Virgen del Rocio University Hospital, Seville, Spain (J.J.E.-G.).

15. Institute of Psychiatry and Neurology, Warsaw, Poland (M.K.).

16. Department of Neurology, Bispebjerg Hospital and University of Copenhagen, Denmark (H.C.).

17. Stroke Research, School of Medicine, Keele University, Newcastle-Under-Lyme, United Kingdom (C.R.).

18. Department of Neurology, Semmelweis University, Budapest, Hungary (D.B.).

19. Selcuk University Faculty of Medicine, Department of Neurology, Konya, Turkey (S.O.).

20. Department of Surgery, Division of Neurosurgery, National University of Malaysia. (J.T.)

21. Age Related Health Care/Stroke-Service, Tallaght University Hospital, Dublin, Republic of Ireland (R.C.).

22. The First University Clinic of Tbilisi State Medical University, GA (M.B.).

23. Neurology and Stroke Unit, Poma Hospital, ASST di Mantova, Mantua, Italy (A.C.).

24. Nottingham Clinical Trials Unit, University of Nottingham, United Kingdom. (L.D.)

25. Research and Innovation, University of Nottingham, United Kingdom. (A.S.)

Abstract

Background and Purpose: Seeking consent rapidly in acute stroke trials is crucial as interventions are time sensitive. We explored the association between consent pathways and time to enrollment in the TICH-2 (Tranexamic Acid in Intracerebral Haemorrhage-2) randomized controlled trial. Methods: Consent was provided by patients or by a relative or an independent doctor in incapacitated patients, using a 1-stage (full written consent) or 2-stage (initial brief consent followed by full written consent post-randomization) approach. The computed tomography-to-randomization time according to consent pathways was compared using the Kruskal-Wallis test. Multivariable logistic regression was performed to identify variables associated with onset-to-randomization time of ≤3 hours. Results: Of 2325 patients, 817 (35%) gave self-consent using 1-stage (557; 68%) or 2-stage consent (260; 32%). For 1507 (65%), consent was provided by a relative (1 stage, 996 [66%]; 2 stage, 323 [21%]) or a doctor (all 2-stage, 188 [12%]). One patient did not record prerandomization consent, with written consent obtained subsequently. The median (interquartile range) computed tomography-to-randomization time was 55 (38–93) minutes for doctor consent, 55 (37–95) minutes for 2-stage patient, 69 (43–110) minutes for 2-stage relative, 75 (48–124) minutes for 1-stage patient, and 90 (56–155) minutes for 1-stage relative consents ( P <0.001). Two-stage consent was associated with onset-to-randomization time of ≤3 hours compared with 1-stage consent (adjusted odds ratio, 1.9 [95% CI, 1.5–2.4]). Doctor consent increased the odds (adjusted odds ratio, 2.3 [1.5–3.5]) while relative consent reduced the odds of randomization ≤3 hours (adjusted odds ratio, 0.10 [0.03–0.34]) compared with patient consent. Only 2 of 771 patients (0.3%) in the 2-stage pathways withdrew consent when full consent was sought later. Two-stage consent process did not result in higher withdrawal rates or loss to follow-up. Conclusions: The use of initial brief consent was associated with shorter times to enrollment, while maintaining good participant retention. Seeking written consent from relatives was associated with significant delays. Registration: URL: https://www.isrctn.com ; Unique identifier: ISRCTN93732214.

Publisher

Ovid Technologies (Wolters Kluwer Health)

Subject

Advanced and Specialised Nursing,Cardiology and Cardiovascular Medicine,Clinical Neurology

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号  京ICP备18003416号-3